Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Advaxis
Work at Advaxis?
Add yourself to this profile
2932
Advaxis
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies. $ADXS
Edit Profile
advaxis.com
Technology
>
Biotechnology
Health Care
>
Medical
>
Diagnostics
>
Health Diagnostics
B2c
Founded in
2002
Raised
$30M
More info
Elsewhere
Companies in the same industry
Alliqua
Exact Sciences
ProMetic
Neurovation Labs
Exosome Diagnostics
AltheaDx
MorphoSys AG
CD Diagnostics
LipoScience
ID Genomics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Post-IPO equity
$30,000,000
Jefferies
,
Guggenheim Securities
,
Cantor Fitzgerald
Employees
Team size
10+
Locations
HQ
United States
Headquarters
Xconomy
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy
Robotics
Health
$30,000,000
Post-IPO equity
New Jersey Business Magazine
Advaxis Secures $30M Direct Placement Financing
Stock markets
The Motley Fool
Why Advaxis, Inc. Stock Rose 19.6% in May
The Motley Fool
Profit-Taking Clobbers Advaxis, Inc. in April Despite Positive PR
Health
Stock markets
The Motley Fool
Here's Why Advaxis Inc.'s Stock Roared Higher in March
The Motley Fool
Why Advaxis, Inc. Shares Are Soaring 16% Today
Health
Stock markets
The Motley Fool
Why Advaxis Gained 20% in 2015 --
The Motley Fool
Why Advaxis, Inc Shares are Skyrocketing Today --
Health
Stock markets
The Motley Fool
Here's Why Advaxis' Stock Gained 11% in October --
Alliqua
Exact Sciences
ProMetic
Neurovation Labs
Exosome Diagnostics
AltheaDx
MorphoSys AG
CD Diagnostics